- Home
- EVG vs ORMP Comparison
EVG vs ORMP Comparison
Compare EVG & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
EVG
Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Current Price
Company Overview
Basic Information| Metric | EVG | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.9M | 165.3M |
| IPO Year | 2004 | 2010 |
Fundamental Metrics
Financial Performance| Metric | EVG | ORMP |
|---|---|---|
| Price | $10.65 | $3.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.8K | ★ 193.8K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.01 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $10.40 | $1.98 |
| 52 Week High | $11.45 | $5.01 |
Technical Indicators
Market Signals| Indicator | EVG | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 39.69 |
| Support Level | $10.61 | $3.21 |
| Resistance Level | $11.06 | $3.72 |
| Average True Range (ATR) | 0.13 | 0.23 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 25.00 | 7.06 |
Price Performance
Historical ComparisonAbout EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.